Effects of cimetidine on caffeine disposition in smokers and nonsmokers
- PMID: 7075114
- DOI: 10.1038/clpt.1982.91
Effects of cimetidine on caffeine disposition in smokers and nonsmokers
Abstract
The absorption, distribution, and elimination of caffeine, 2 mg/kg by mouth, were evaluated in six smokers and six nonsmokers before and on the fourth day of administration of cimetidine, 300 mg by mouth every 6 hr. Caffeine absorption, assessed by the maximal serum caffeine concentration (C max) and the time to reach Cmax (t max), was very rapid relative to elimination. The total body clearance (TBC) of caffeine was higher (2.49 +/- 0.35 and 1.59 +/- 0.19 ml/kg/min, P less than 0.05) and the elimination half-life (t1/2) shorter (190 +/- 15 and 276 +/- 30 min, P less than 0.05) in smokers than nonsmokers, but Cmax, tmax, and the apparent volume of distribution (Vd, app) did not differ (P greater than 0.05). Cimetidine decreased the TBC of caffeine by 31% (to 1.73 +/- 0.28 ml/kg/min, P less than 0.05) and by 42% (to 0.92 +/- 0.11 ml/kg/min, P less than 0.01) in smokers and nonsmokers. The increases in t1/2 were 45% (to 276 +/- 25 min, P less than 0.05) and 96% (to 542 +/- 123 min, P less than 0.05). Cmax, tmax, and Vd, app were unaffected by cimetidine. Caffeine induced similar slight increases in blood pressure and pulse rate in smokers and nonsmokers both before and during cimetidine dosing.
Similar articles
-
Effect of smoking on caffeine clearance.Clin Pharmacol Ther. 1978 Jul;24(1):40-5. doi: 10.1002/cpt197824140. Clin Pharmacol Ther. 1978. PMID: 657717
-
Decreased systemic clearance of caffeine due to cimetidine.Br J Clin Pharmacol. 1981 Aug;12(2):155-9. doi: 10.1111/j.1365-2125.1981.tb01194.x. Br J Clin Pharmacol. 1981. PMID: 7306430 Free PMC article. Clinical Trial.
-
Cigarette smoking and theophylline metabolism: effects of cimetidine.Clin Pharmacol Ther. 1985 Mar;37(3):330-6. doi: 10.1038/clpt.1985.48. Clin Pharmacol Ther. 1985. PMID: 3971657
-
Drug interactions with cimetidine.Clin Pharmacokinet. 1982 Jan-Feb;7(1):23-41. doi: 10.2165/00003088-198207010-00002. Clin Pharmacokinet. 1982. PMID: 7042171 Review. No abstract available.
-
Clinical pharmacokinetics of cimetidine.Clin Pharmacokinet. 1983 Nov-Dec;8(6):463-95. doi: 10.2165/00003088-198308060-00001. Clin Pharmacokinet. 1983. PMID: 6418428 Review.
Cited by
-
Effect of cimetidine on digoxin disposition in peptic ulcer patients.Eur J Clin Pharmacol. 1986;30(4):489-91. doi: 10.1007/BF00607966. Eur J Clin Pharmacol. 1986. PMID: 3743626 Clinical Trial.
-
Pharmacokinetic interactions of cimetidine 1987.Clin Pharmacokinet. 1987 May;12(5):321-66. doi: 10.2165/00003088-198712050-00002. Clin Pharmacokinet. 1987. PMID: 3301148 Review.
-
Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).Clin Pharmacokinet. 1990 Aug;19(2):94-125. doi: 10.2165/00003088-199019020-00002. Clin Pharmacokinet. 1990. PMID: 2199130 Review.
-
Quantitative Prediction of Drug Interactions Caused by CYP1A2 Inhibitors and Inducers.Clin Pharmacokinet. 2016 Aug;55(8):977-90. doi: 10.1007/s40262-016-0371-x. Clin Pharmacokinet. 2016. PMID: 26936044
-
The impact of caffeine on vasodilator stress perfusion studies.J Nucl Cardiol. 2004 Jul-Aug;11(4):506-11. doi: 10.1016/j.nuclcard.2004.04.003. J Nucl Cardiol. 2004. PMID: 15295419 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical